SAN FRANCISCO, Nov. 7, 2013 /PRNewswire via COMTEX/ -- Nektar Therapeutics /quotes/zigman/89920/delayed/quotes/nls/nktr NKTR +6.25% today reported its financial results for the third quarter ended September 30, 2013.
Cash and investments in marketable securities at September 30, 2013 were $208.6 million as compared to $302.2 million at December 31, 2012.
Help employers find you! Check out all the jobs and post your resume.
